X

Healthcare

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Transcript

Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Sudhir Menon -- Executive Director, (Finance) and…

Indoco Remedies Limited (INDOCO) Q3 FY23 Earnings Concall Transcript

Indoco Remedies Limited (NSE: INDOCO) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Aditi Panandikar -- Managing Director Sundeep V.…

Granules India Ltd (GRANULES) Q3 FY23 Earnings Concall Transcript

Granules India Ltd (NSE: GRANULES) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Irfan Raeen -- Investor Relation Advisor Krishna…

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

Syngene International Ltd (NSE: SYNGENE) Q3 FY23 Earnings Concall dated Jan. 24, 2023 Corporate Participants: Avantika Mishra -- Associate - EY Jonathan…

Syngene International Ltd (SYNGENE) Q3 FY23 Earnings Concall Transcript

Syngene International Ltd  (NSE: SYNGENE) Q3 FY23 Earnings Concall dated January 24, 2023 Corporate Participants: Avantika Mishra -- Associate - EY Jonathan…

Gland Pharma Limited (GLAND) Q3 FY23 Earnings Concall Transcript

Gland Pharma Limited (NSE:GLAND) Q3 FY23 Earnings Concall dated Jan. 23, 2023. Corporate Participants: Sumanta Bajpayee -- Vice President, Finance and Investor…

Apollo Hospitals: Ushering in a New Era

“Our hospital business is on a very strong growth trajectory and will continue to grow. We will improve not only…

Shalby Ltd. Q2FY23; 71% Growth in Profits

Shalby Ltd.‘s revenues in Q2FY23 rose 11% to ₹ 2,018 millions. Consolidated Profit After Tax came at ₹ 184 millions…

Shalby Limited: A Rising Star?

“With all key strategies in place, our team is extremely committed to flawless execution of these strategies. Shalby is very…

IOL Chemicals and Pharmaceuticals Limited (IOLCP) Q2 FY23 Earnings Concall Transcript

IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Sanjay Chaturvedi -- Executive Director and…